Immunotech Biopharm Ltd

06978

Company Profile

  • Business description

    Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.

  • Contact

    No.1 Kangding Street
    8th Floor, Block 1, Guosheng Technology Park
    Beijing Economic-technological Development Area
    Beijing100176
    CHN

    T: +86 1088400152

    https://www.eaal.net

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    202

Stocks News & Analysis

stocks

An ASX share to avoid

Investors are overly optimistic about the prospects for this company. 
stocks

Unconventional wisdom: A controversial income pick

Rigid definitions of income and growth shares may be holding investors back.
stocks

How to avoid dividend disaster

Thinking about common reasons a company might stop paying a dividend can help income investors avoid disappointment.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,780.304.80-0.05%
CAC 407,973.0334.59-0.43%
DAX 4021,787.00115.42-0.53%
Dow JONES (US)44,303.40444.23-0.99%
FTSE 1008,700.5326.75-0.31%
HKSE21,133.54241.921.16%
NASDAQ19,523.40268.59-1.36%
Nikkei 22538,787.02279.51-0.72%
NZX 50 Index12,902.1957.600.45%
S&P 5006,025.9957.58-0.95%
S&P/ASX 2008,511.409.30-0.11%
SSE Composite Index3,303.6733.011.01%

Market Movers